Update of hepatitis C therapy in patients with chronic kidney disease on hemodialysis
Hepatitis C virus (HCV), causative agent of hepatitis C, was discovered 25 years ago. Most patients develop chronic HCV infection (55-85 %), which manifests with hepatic complications (cirrhosis, hepatocellular carcinoma) and extrahepatic ones. This virus is endemic in hemodialysis (HD) units, many...
Main Author: | Silvina G. Tártara |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Asociación Regional de Diálisis y Trasplantes Renales de Capital Federal y Provincia de Buenos Aires
2017-09-01
|
Series: | Revista de Nefrología, Diálisis y Trasplante |
Subjects: | |
Online Access: | http://www.revistarenal.org.ar/index.php/rndt/article/view/188 |
Similar Items
-
Hepatitis C in patients with chronic kidney disease: the opportunity to eradicate it has come. Review of management in this population with the advent of new direct-acting antivirals
by: Marcelo O. Silva, et al.
Published: (2018-03-01) -
Characterization of patients with hepatitis B and C in hemodialysis
by: Nuris de las Mercedes Begué Dalmau, et al.
Published: (2016-02-01) -
COVID-19 in patients with chronic kidney disease on hemodialysis
by: Tomás de Armas Gil, et al.
Published: (2021-02-01) -
Estudio multicéntrico español PIBHE: prevalencia e inmunización de la infección crónica por el virus de la hepatitis B en pacientes en hemodiálisis en España
by: Rebeca García Agudo, et al.
Published: (2016-03-01) -
Clinical epidemiological and endoscopic characteristics in carriers of the viral hepatitis C with hemodialysis treatment
by: Mariblanca González Purón, et al.
Published: (2022-12-01)